| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Basic Science Investigations |
1 Medical Department, Brookhaven National Laboratory, Upton, New York
2 Chemistry Department, Brookhaven National Laboratory, Upton, New York
3 Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon
The use of mice with targeted gene deletions (knockouts [KOs]) provides an important tool to investigate the mechanisms underlying behavior, neuronal development, and the sequella of neuropsychiatric diseases. MRI has been used to image brain structural changes in KO mice but, to our knowledge, the feasibility of using PET to investigate brain neurochemistry in KO mice has not been demonstrated. Methods: We have evaluated the sensitivity of the microPET to image dopamine D2 receptor (DRD2) KO mice (D2-/-). PET measurements were performed in wild-type (D2+/+) mice and KO (D2-/-) mice using a microPET scanner. Briefly, each animal was anesthetized and injected intravenously with 11C-raclopride, a DRD2-specific ligand, and dynamic PET scanning was performed for 60 min. Results: The 11C-raclopride images of the KO mice showed significantly lower binding in the striatum (ST) than those of the wild-type (WT) mice, which was confirmed by the time-activity curves that revealed equivalent binding in the ST and cerebellum (CB) in KO mice, whereas the WT mice had significantly higher binding in the ST than in the CB. The ST/CB ratio was significantly higher in WT mice than in KO mice (ST/CB = 1.33 ± 0.13 and 1.05 ± 0.03, respectively; P < 0.002; n = 10). The microPET images were compared qualitatively with conventional autoradiography images. Conclusion: These data support the use of microPET as an effective in vivo imaging tool for studying noninvasively KO mice. These same tools can be extended to investigate other genetically engineered murine models of disease. Future studies will seek to use microPET to investigate the relationships between genes, neuronal activity, and behavior.
Key Words: brain • gene therapy • animal model • psychiatry • drug abuse
This article has been cited by other articles:
|
|
 |
|
  A. Wallen-Mackenzie, K. Nordenankar, K. Fejgin, M. C. Lagerstrom, L. Emilsson, R. Fredriksson, C. Wass, D. Andersson, E. Egecioglu, M. Andersson, et al. Restricted Cortical and Amygdaloid Removal of Vesicular Glutamate Transporter 2 in Preadolescent Mice Impacts Dopaminergic Activity and Neuronal Circuitry of Higher Brain Function J. Neurosci., February 18, 2009; 29(7): 2238 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kitada, A. Pisani, D. R. Porter, H. Yamaguchi, A. Tscherter, G. Martella, P. Bonsi, C. Zhang, E. N. Pothos, and J. Shen From the Cover: Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice PNAS, July 3, 2007; 104(27): 11441 - 11446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Rodriguez-Gomez, J.-Q. Lu, I. Velasco, S. Rivera, S. S. Zoghbi, J.-S. Liow, J. L. Musachio, F. T. Chin, H. Toyama, J. Seidel, et al. Persistent Dopamine Functions of Neurons Derived from Embryonic Stem Cells in a Rodent Model of Parkinson Disease Stem Cells, April 1, 2007; 25(4): 918 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Honer, M. Bruhlmeier, J. Missimer, A. P. Schubiger, and S. M. Ametamey Dynamic Imaging of Striatal D2 Receptors in Mice Using Quad-HIDAC PET J. Nucl. Med., March 1, 2004; 45(3): 464 - 470. [Abstract] [Full Text]
|
|
|
|
|
|
D. L. Alexoff, P. Vaska, D. Marsteller, T. Gerasimov, J. Li, J. Logan, J. S. Fowler, N. B. Taintor, P. K. Thanos, and N. D. Volkow Reproducibility of 11C-Raclopride Binding in the Rat Brain Measured with the MicroPET R4: Effects of Scatter Correction and Tracer Specific Activity J. Nucl. Med., May 1, 2003; 44(5): 815 - 822. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
